27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

EMPLOYEES: 235 employees<br />

HISTORY: Founded in 1993<br />

Acquired SynX Pharma Inc. (4/04)<br />

Merged with Epoch Biosciences Inc. (12/04)<br />

To acquire Spectral Diagnostic Inc.’s rapid cardiac immunoassay test<br />

business (as of 12/05)<br />

To acquire the diagnostics division of Amplimedical SpA (as of 4/06)<br />

FACILITIES: 51,000 sq. ft. in San Diego, Calif.<br />

30,000 sq. ft. in Bothell, Wash.<br />

50,000 sq. ft. in Toronto, Canada<br />

2,600 sq. ft. in Helmond, Netherlands<br />

STOCK-FINANCIAL HISTORY: NASDAQ--NGEN<br />

IPO--3.9M shares at $11/share, $42.9M (4/98)<br />

Secondary offering--$80M (11/00)<br />

Revenue $12.544M (YE 05) compared to $5.374M (YE 04)<br />

Net loss (YE 05) compared to (YE 04)<br />

Loss per share (YE 05) compared to (YE 04)<br />

Average shares outstanding 49.585M (YE 05) compared to 32.203M (YE<br />

04)<br />

Total assets $98.081M (YE 05) compared to $176.024M (YE 04)<br />

PRIVATE PLACEMENTS: Raised $26.2M through private placement of Series C preferred stock (3/97)<br />

Raised $20M through private placement of 6.8M shares and 1M warrants<br />

(9/05)<br />

SUBSIDIARIES/DIVISIONS: Molecular Research Products division:<br />

21720 23rd Drive S.E., No. 150<br />

Bothell, WA 98021<br />

Phone: (800) 562-5544<br />

Fax: (425) 482-5550<br />

E-mail: molecularresearch@nanogen.com<br />

Point of Care Diagnostics division:<br />

1 Marmac Drive<br />

Toronto , Ontario<br />

M9W 1E7 Canada<br />

Phone: (877) 246-7593<br />

Fax: (416) 798-3447<br />

E-mail: nanogenpoc@nanogen.com<br />

Nanogen Europe BV:<br />

Steenovenweg 3<br />

5708 HN Helmond<br />

Netherlands<br />

Phone: +31 (0)492-507-160<br />

Fax: +31 (0)492-507-179<br />

PRINCIPAL INVESTORS: Birndorf Biotechnology Development<br />

Enterprise Partners<br />

InterWest Partners<br />

Kleiner, Perkins, Caufield and Byers<br />

New Leaf Venture Partners<br />

INVESTMENTS: Jurilab Ltd.<br />

FINANCIAL INFORMATION: Completed $3.5M round of venture capital financing (2/94)<br />

Completed $9.5M round of venture capital financing (10/95)<br />

Received $2M two-year grant from U.S. Department of Commerce (7/95)<br />

Received $500K grant from Bude Technology Group (4/96)<br />

Received $250K grant from the State of California Defense Conversion<br />

Matching Grant (6/96)<br />

Copyright ©2006 AHC Media ® 256

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!